chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Angiogram pulmonary normal, Basophil count decreased, Basophil percentage decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: C-reactive protein increased, Chest X-ray normal, Chest pain, Computerised tomogram normal, Differential white blood cell count
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Dyspnoea, Echocardiogram normal, Eosinophil count decreased, Eosinophil percentage decreased, Haematocrit normal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Haemoglobin normal, Headache, Lymphocyte count normal, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal, Monocyte count increased, Monocyte percentage increased
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Neutrophil count normal, Neutrophil percentage, Platelet count normal, Pyrexia, Red blood cell count normal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Red blood cell sedimentation rate normal, Red cell distribution width normal, Troponin T, White blood cell count normal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07-Apr-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown and a dose of Anthrax (lot number FAV213, manufacturer: Michigan DPH) via unknown route and site of administration. The patient did not have any medical history and current illnesses. The other medications and prior vaccination details were not provided. On 17-Apr-2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever and troubled deep breathing due to pain in chest. The patient required emergency visit and was hospitalized on an unspecified date. Laboratory investigations done on 17-Apr-2010 included: WBC Blood (White Blood Cells) 9.0 x 10 (E3) /mcL; RBC Blood (Red Blood Cells) 4.75 x 10 (E6) mcL; Hemoglobin Blood, 15.3 g/dL; Hematocrit Blood, 42.8%; MCV Blood (Mean Corpuscular Volume), 90.1 fL; MCH Blood (Mean Corpuscular Hemoglobin), 32.2 pg; MCHC Blood (Mean Cell Hemoglobin Concentration), 35.7 g/dL; RDW CV Blood (Red Cell Distrubution Width), 12.8%; Platelets Blood, 158 x 10 (3) /mcL;  MPV Blood (Mean Platelet Volume), 10.9 fL; Neutrophils Blood, 6.1 x 10 (3) / mcL; Neutrophils Blood, 68%; Lymphocytes Blood, 1.6 x 10 (3) /mcL; Lymphocytes Blood, 17.8%; Monocytes Blood, 1.2 (H) x 10 (3) /mcL; Monocytes Blood, 13.2% (H); Eosinophils Blood, 0.1 x 10 (3) /mcL; Eosinophils Blood, 0.6%; Basophils Blood, 0%. Other tests included Angiogram Pulmonary, Chest X-ray, Computerised Tomogram and Echocardiogram, the results of all the tests was normal. The basophil count, basophil percentage, eosinophil count, lymphocyte percentage and mean platelet volume were decreased, blood creatine phosphokinase MB, C-Reactive Protein, Mean Cell Haemoglobin, Monocyte Count and Monocyte Percentage were increased. The results for Differential White Blood Cell Count, Neutrophil Percentage and Troponin T results were not provided. The results for Blood Creatine Phosphokinase, Eosinophil Count, Haematocrit, Haemoglobin, Lymphocyte Count, Mean Cell Haemoglobin Concentration, Mean Cell Volume, Neutrophil Count, platelet count, Red Blood Cell count, red blood cell sedimentation rate, red cell distribution width and white blood cell count, were normal. Laboratory test was abnormal. Corrective treatment was not provided. At the time of this report, the patient recovered from the above mentioned events on an unspecified date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Injection site inflammation, Injection site pain
Clinical narrative: This unsolicited case was received on 09 August 2010 via a search on the VAERS database, under the reference number 386430. The country of occurrence is unknown/not reported; the country of the reporter is unknown/not reported; and the country where the patient was vaccinated is unknown/not reported. A 21-year-old male patient received the following vaccinations on 20 April 2010: a dose of ACAM2000, lot number VV04003A and a dose of BIOTHRAX, lot number FAV230. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient developed 8 days later inflammation and tenderness at the site of injection on the left arm. The inflammation was spreading on the upper arm. The patient was seen in the emergency room for a doctor visit. The outcome was reported as unknown. Follow up information received from a healthcare professional on 10-Aug-2015 via a third party query tool search on the VAERS database. The VAERS ID reference number for this case is was 386430. The patient received ACAM2000 vaccine (manufacturer: Sanofi Pasteur Biologics Co.) via unknown route in the left arm and BIOTHRAX vaccine (manufacturer: Emergent) via intramuscular route in the right arm. Concomitant medication was not reported. The patient did not have any medical history and current illness. The other medications and prior vaccinations were not reported. There were no laboratory investigations done and corrective treatment was not provided. At the time of this report, the outcome was reported as unknown. Documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Condition aggravated, Decreased appetite, Diarrhoea, Fatigue, Heart rate abnormal
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 387051. A 28-years-old male patient received the following vaccination on 23-Feb-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown. The patient denied any current illnesses. He had history of migraine headaches. The other medications, laboratory data and prior vaccination details were not provided. On 24-Feb-2010, 1 day post-vaccination, the patient developed migraine headache, followed by nausea, vomiting and diarrhea. On 23-Mar-2010 he was seen for a two week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever, and non healed vaccination site. The patient required hospital admission and was admitted on an unspecified date. It was reported that on 5-Apr-2010, the vaccination site was healing and was being followed by neurology for intractable headache. It was reported attempts were made to contact the patient however there was no response. Corrective treatments were not provided. At the time of this report, the outcome was reported as unknown. List of documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Malaise, Migraine, Nausea, Pain, Pyrexia
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 387051. A 28-years-old male patient received the following vaccination on 23-Feb-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown. The patient denied any current illnesses. He had history of migraine headaches. The other medications, laboratory data and prior vaccination details were not provided. On 24-Feb-2010, 1 day post-vaccination, the patient developed migraine headache, followed by nausea, vomiting and diarrhea. On 23-Mar-2010 he was seen for a two week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever, and non healed vaccination site. The patient required hospital admission and was admitted on an unspecified date. It was reported that on 5-Apr-2010, the vaccination site was healing and was being followed by neurology for intractable headache. It was reported attempts were made to contact the patient however there was no response. Corrective treatments were not provided. At the time of this report, the outcome was reported as unknown. List of documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: SMALL
Symptoms: Tremor, Vaccination site reaction, Vomiting
Clinical narrative: This unsolicited case was received on 10-Aug-2015 via a third party query tool search on the VAERS database, under reference number 387051. A 28-years-old male patient received the following vaccination on 23-Feb-2010: A dose of ACAM2000 (lot number VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) via "intradermal" route, site of administration was unknown. The patient denied any current illnesses. He had history of migraine headaches. The other medications, laboratory data and prior vaccination details were not provided. On 24-Feb-2010, 1 day post-vaccination, the patient developed migraine headache, followed by nausea, vomiting and diarrhea. On 23-Mar-2010 he was seen for a two week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever, and non healed vaccination site. The patient required hospital admission and was admitted on an unspecified date. It was reported that on 5-Apr-2010, the vaccination site was healing and was being followed by neurology for intractable headache. It was reported attempts were made to contact the patient however there was no response. Corrective treatments were not provided. At the time of this report, the outcome was reported as unknown. List of documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Blister, Erythema, Lymphadenopathy, Orthopoxvirus test positive, Polymerase chain reaction positive
Clinical narrative: SERIOUS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. This case was received on 23 September 2014 via a third party query tool search on the VAERS database, under reference number: 534449. A 19-year-old male patient was exposed to a vaccinated person on 06 June 2014. The patient's roommate had received an injection of ACAM2000 (lot number not reported) in the left arm on 20 May 2014. The patient did not receive the vaccine himself. On 08 June 2014, 2 days after the patient was exposed to the vaccinated person, he experienced vesicles and bumps on the left upper arm, in the area of a recent tattoo that was done a week before, on 01 June 2014. Increased in size and redness were described; lymph nodes in his armpit was also reported. Patient denied fever. He was evaluated at a clinic and sent to the dermatologist on an unspecified date for further evaluation. Specimens were obtained on 13 June 2014, including culture for PCR, The specimens tested were positive for both orthopox and non-variola orthopox PCR targets. Smallpox vaccine precautions were reviewed with the patient. Other medications, current illnesses and history were reported as none. On follow-up done on 17 June 2014, patient was doing well. Area was healing nicely. There was no drainage and no new lesions. Patient outcome was reported as recovered. Documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Rash
Clinical narrative: SERIOUS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. This case was received on 23 September 2014 via a third party query tool search on the VAERS database, under reference number: 534449. A 19-year-old male patient was exposed to a vaccinated person on 06 June 2014. The patient's roommate had received an injection of ACAM2000 (lot number not reported) in the left arm on 20 May 2014. The patient did not receive the vaccine himself. On 08 June 2014, 2 days after the patient was exposed to the vaccinated person, he experienced vesicles and bumps on the left upper arm, in the area of a recent tattoo that was done a week before, on 01 June 2014. Increased in size and redness were described; lymph nodes in his armpit was also reported. Patient denied fever. He was evaluated at a clinic and sent to the dermatologist on an unspecified date for further evaluation. Specimens were obtained on 13 June 2014, including culture for PCR, The specimens tested were positive for both orthopox and non-variola orthopox PCR targets. Smallpox vaccine precautions were reviewed with the patient. Other medications, current illnesses and history were reported as none. On follow-up done on 17 June 2014, patient was doing well. Area was healing nicely. There was no drainage and no new lesions. Patient outcome was reported as recovered. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Alanine aminotransferase, Blood creatinine normal, Blood glucose normal, Blood urea normal, Chest pain
Clinical narrative: This case was received on 23 September 2014 via a third party query tool search on the VAERS database, under reference number 534641. A 22-year-old male patient had received the following vaccinations on 16 June 2014: ACAM2000 (SP Biologics Co. lot number, route and site were not reported). On 19 June 2014, the patient experienced a sore throat, yellow cough, hard to breathe, chest hurt from coughing, chills and fever. The patient went to the emergency room and laboratory tests were: white blood count (WBC) - 7.5, platelets (plt) 202, hemoglobin (hgb) 14.7, neutrophil percentage (neuts) 70.6%, creatinine (scr) 1.1, blood glucose (glucose) 104, aspartate aminotransferase (ast) 15, alanine aminotransferase (alt) 16, blood urea (bun) 13, temperature 36.8, BP 126/67, RR-18, pulse ox-98 and pain 6/10. The patient's current illnesses, other medications and history were unknown. Treatment details were not reported. The patient outcome was unknown. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Chills, Cough, Dyspnoea, Haemoglobin normal, Neutrophil percentage increased
Clinical narrative: This case was received on 23 September 2014 via a third party query tool search on the VAERS database, under reference number 534641. A 22-year-old male patient had received the following vaccinations on 16 June 2014: ACAM2000 (SP Biologics Co. lot number, route and site were not reported). On 19 June 2014, the patient experienced a sore throat, yellow cough, hard to breathe, chest hurt from coughing, chills and fever. The patient went to the emergency room and laboratory tests were: white blood count (WBC) - 7.5, platelets (plt) 202, hemoglobin (hgb) 14.7, neutrophil percentage (neuts) 70.6%, creatinine (scr) 1.1, blood glucose (glucose) 104, aspartate aminotransferase (ast) 15, alanine aminotransferase (alt) 16, blood urea (bun) 13, temperature 36.8, BP 126/67, RR-18, pulse ox-98 and pain 6/10. The patient's current illnesses, other medications and history were unknown. Treatment details were not reported. The patient outcome was unknown. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Oropharyngeal pain, Platelet count normal, Pyrexia, White blood cell count normal
Clinical narrative: This case was received on 23 September 2014 via a third party query tool search on the VAERS database, under reference number 534641. A 22-year-old male patient had received the following vaccinations on 16 June 2014: ACAM2000 (SP Biologics Co. lot number, route and site were not reported). On 19 June 2014, the patient experienced a sore throat, yellow cough, hard to breathe, chest hurt from coughing, chills and fever. The patient went to the emergency room and laboratory tests were: white blood count (WBC) - 7.5, platelets (plt) 202, hemoglobin (hgb) 14.7, neutrophil percentage (neuts) 70.6%, creatinine (scr) 1.1, blood glucose (glucose) 104, aspartate aminotransferase (ast) 15, alanine aminotransferase (alt) 16, blood urea (bun) 13, temperature 36.8, BP 126/67, RR-18, pulse ox-98 and pain 6/10. The patient's current illnesses, other medications and history were unknown. Treatment details were not reported. The patient outcome was unknown. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site reaction, Skin lesion
Clinical narrative: This case was received on 17 October 2014 via a third party query tool search on the VAERS database, under reference number 535735. A 19 year-old male patient had received on 21 May 2014 a right arm dose 1 ACAM2000 (lot number VV04003A). The patient reported to clinic on 30 May 2014 with a complaint of multiple lesions on right deltoid after receiving a tattoo to the area on 23 may 2014 which had been against medical advice. The patient was evaluated by a provider and treated with BENADRYL and Ibuprofen. The patient was instructed on care of the lesions and was to follow-up every two days. No further information was provided. Outcome was unknown. Documents held by sender: none.
Age: 47.0
Sex: M
Vaccine: SMALL
Symptoms: Herpes zoster, Hyperaesthesia, Pruritus, Rash pustular
Clinical narrative: Initial report was received on 17 October 2014 via a third party query tool search on the VAERS database, under reference number 536849. A 47-year-old male patient had received an injection of SMALLPOX (lot number, route and site of administration were not reported) on 24 June 2012. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of patient's vaccination. On 10 July 2012, i.e. 16 days post vaccination, the patient experienced pustules below the belt line, just above genitals, and on buttocks with itching and sensitivity appeared a few weeks later. He went on sick call a few weeks after symptoms and diagnosis was unknown at that time. He was given corrective treatment with ketoconazole topical solution to relieve symptoms. Symptoms reappeared every 2-3 months. He went for a consultation with his healthcare provider around July 2013 and herpes was diagnosed. He was then prescribed Valacyclovir HCL1. Current illnesses, History and lab data were reported as none. It was unknown whether the patient had received prior vaccination. At the tine of the report, the patient was not recovered. Documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Dyspnoea, Rash generalised, Rash pustular
Clinical narrative: This case was received on 17October 2014 via a third party query tool search on the VAERS database, under reference 538110. A 32 year-old male patient with no history and no current illnesses, had received the following vaccinations on 02 March 2010: a left arm dose 0, ACAM2000 (lot number VV04003A), and an intramuscular right arm injection of BIOTHRAX (lot number FAV223) and one day later on 03 March 2010, experienced labored breathing and broke out in pus filled bumps all over their body ("not just localized area like vaccine should caused"). The patient had an emergency visit and was hospitalized. Lab data, other medications and prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 21.0
Sex: F
Vaccine: SMALL
Symptoms: Scar
Clinical narrative: This unsolicited case was received on 05 January 2015 via a third party query tool search on the VAERS database, under reference number 538519. A 21 year-old female with no current illnesses had received on 11 May 2013 a dose 0 left arm injection of ACAM2000 (lot number VV04003A) and an unspecified amount of time later, experienced excessive scarring. History, lab data, other medications and prior vaccinations were not reported. Outcome was recovered. Documents held by sender: none.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Burning sensation, Paraesthesia, Polymerase chain reaction positive, Scar, Skin lesion
Clinical narrative: This unsolicited case was received on 05 December 2014 via a third party query tool search on the VAERS database, under reference number 545146. A 30 year-old male (date of birth not reported) had received on 04 June 2014 an injection of ACAM2000 (lot number and site of administration not reported) and 2 days later on 06 June 2014, experienced multiple lesions to the chin and neck area, scarring, tingling and burning. The patient was hospitalized. Laboratory data included a positive PCR for vaccinia. Other medications, current illnesses and history were reported as "none". Prior vaccinations were not reported. Outcome was recovered. Documents held by sender: none.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Vaccinia test positive
Clinical narrative: This unsolicited case was received on 05 December 2014 via a third party query tool search on the VAERS database, under reference number 545146. A 30 year-old male (date of birth not reported) had received on 04 June 2014 an injection of ACAM2000 (lot number and site of administration not reported) and 2 days later on 06 June 2014, experienced multiple lesions to the chin and neck area, scarring, tingling and burning. The patient was hospitalized. Laboratory data included a positive PCR for vaccinia. Other medications, current illnesses and history were reported as "none". Prior vaccinations were not reported. Outcome was recovered. Documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL
Symptoms: Arthralgia, Blood uric acid increased, Erythema, Gout, Inflammatory marker test
Clinical narrative: This unsolicited case was received on 05 December 2014 via a third party query tool search on the VAERS database, under reference number 545532. A 27-year-old male patient with an unknown medical history and concomitant medications was vaccinated with ACAM2000, batch number VV04003A into the left arm on 01 August 2014. The patient had no current illness at the time of vaccination. On approximately 18 August 2014 (onset date also reportetd as 14 August 2014), he began to notice single red dots to his chest and right arm. These "mosquito bite" like dots did itch. The patient denied any other lesions, macules or skin rashes, no chest pain, breathing difficulty, arthralgia, myalgia, headaches or other systemic reactions. His ACAM vaccination site was still moist with gray like edges and a dark center. On 20 August 2014, these red dots spread to bilateral legs and fingers. The macules to his right upper chest seemed patchy, but he had been scratching the site. There were no lesions to his palms of his hands or soles of his feet with no systemicc symptoms. He went to the ER on 20 August 2014 after awakening with left ankle pain and pain to his great toe. He recalls being told his x-rays were negative and labs ("inflammatory studies") were borderline. He was advised to see a rheumatologist, but was told he could have a bunion and his ankle may have cellulitis. He was prescribed BACTRIM on an unknown date for his "cellulitis", and a tapering dose of prednisone (60-50-40 etc.) for the rash. He was prescribed tramadol for the pain. On 21 August 2014, 25 August 2014 and 29 August 2014 he reported his rash had stabilized and was resolving with (1-3 macules on his arms/hands/legs). He had followed up with a rheumatologist and was advised that his red left ankle and later toe was diagnosed as gout (confirmed elevated uric acid). His ACAM vaccinations site was drying and beginning to scab after leaving it open to air while alone. The patient outcome was recovered on an unreported date. The event of cellulitis was coded to maintain coding performed by VAERS, but this case is considered non-serious as cellulitis was later ruled out and the patient was diagnosed with gout. Addendum 30 June 2015: Upon second medical examination of case at the time of interval review the following has been modified in this case: blood uric increased was removed as an event, injection site scab was added as an event, concomitant medications was updated as None. Trade name was updated ini the narrative to ACAM2000, lot number was corrected and administration site was updated to left arm. Documents held by sender: None.
Age: 27.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site discolouration, Injection site scab, Laboratory test normal, Macule, Pain in extremity
Clinical narrative: This unsolicited case was received on 05 December 2014 via a third party query tool search on the VAERS database, under reference number 545532. A 27-year-old male patient with an unknown medical history and concomitant medications was vaccinated with ACAM2000, batch number VV04003A into the left arm on 01 August 2014. The patient had no current illness at the time of vaccination. On approximately 18 August 2014 (onset date also reportetd as 14 August 2014), he began to notice single red dots to his chest and right arm. These "mosquito bite" like dots did itch. The patient denied any other lesions, macules or skin rashes, no chest pain, breathing difficulty, arthralgia, myalgia, headaches or other systemic reactions. His ACAM vaccination site was still moist with gray like edges and a dark center. On 20 August 2014, these red dots spread to bilateral legs and fingers. The macules to his right upper chest seemed patchy, but he had been scratching the site. There were no lesions to his palms of his hands or soles of his feet with no systemicc symptoms. He went to the ER on 20 August 2014 after awakening with left ankle pain and pain to his great toe. He recalls being told his x-rays were negative and labs ("inflammatory studies") were borderline. He was advised to see a rheumatologist, but was told he could have a bunion and his ankle may have cellulitis. He was prescribed BACTRIM on an unknown date for his "cellulitis", and a tapering dose of prednisone (60-50-40 etc.) for the rash. He was prescribed tramadol for the pain. On 21 August 2014, 25 August 2014 and 29 August 2014 he reported his rash had stabilized and was resolving with (1-3 macules on his arms/hands/legs). He had followed up with a rheumatologist and was advised that his red left ankle and later toe was diagnosed as gout (confirmed elevated uric acid). His ACAM vaccinations site was drying and beginning to scab after leaving it open to air while alone. The patient outcome was recovered on an unreported date. The event of cellulitis was coded to maintain coding performed by VAERS, but this case is considered non-serious as cellulitis was later ruled out and the patient was diagnosed with gout. Addendum 30 June 2015: Upon second medical examination of case at the time of interval review the following has been modified in this case: blood uric increased was removed as an event, injection site scab was added as an event, concomitant medications was updated as None. Trade name was updated ini the narrative to ACAM2000, lot number was corrected and administration site was updated to left arm. Documents held by sender: None.
Age: 27.0
Sex: M
Vaccine: SMALL
Symptoms: Rash erythematous, Rash generalised, Rash pruritic, X-ray normal
Clinical narrative: This unsolicited case was received on 05 December 2014 via a third party query tool search on the VAERS database, under reference number 545532. A 27-year-old male patient with an unknown medical history and concomitant medications was vaccinated with ACAM2000, batch number VV04003A into the left arm on 01 August 2014. The patient had no current illness at the time of vaccination. On approximately 18 August 2014 (onset date also reportetd as 14 August 2014), he began to notice single red dots to his chest and right arm. These "mosquito bite" like dots did itch. The patient denied any other lesions, macules or skin rashes, no chest pain, breathing difficulty, arthralgia, myalgia, headaches or other systemic reactions. His ACAM vaccination site was still moist with gray like edges and a dark center. On 20 August 2014, these red dots spread to bilateral legs and fingers. The macules to his right upper chest seemed patchy, but he had been scratching the site. There were no lesions to his palms of his hands or soles of his feet with no systemicc symptoms. He went to the ER on 20 August 2014 after awakening with left ankle pain and pain to his great toe. He recalls being told his x-rays were negative and labs ("inflammatory studies") were borderline. He was advised to see a rheumatologist, but was told he could have a bunion and his ankle may have cellulitis. He was prescribed BACTRIM on an unknown date for his "cellulitis", and a tapering dose of prednisone (60-50-40 etc.) for the rash. He was prescribed tramadol for the pain. On 21 August 2014, 25 August 2014 and 29 August 2014 he reported his rash had stabilized and was resolving with (1-3 macules on his arms/hands/legs). He had followed up with a rheumatologist and was advised that his red left ankle and later toe was diagnosed as gout (confirmed elevated uric acid). His ACAM vaccinations site was drying and beginning to scab after leaving it open to air while alone. The patient outcome was recovered on an unreported date. The event of cellulitis was coded to maintain coding performed by VAERS, but this case is considered non-serious as cellulitis was later ruled out and the patient was diagnosed with gout. Addendum 30 June 2015: Upon second medical examination of case at the time of interval review the following has been modified in this case: blood uric increased was removed as an event, injection site scab was added as an event, concomitant medications was updated as None. Trade name was updated ini the narrative to ACAM2000, lot number was corrected and administration site was updated to left arm. Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: CSF white blood cell count increased, Headache, Malaise, Meningitis, Spinal pain
Clinical narrative: This unsolicited case was received on 22-May-2015 via a third party query tool search on the VAERS database, under reference number 557209. A 38-year-old male patient received the following vaccination on 09-Nov-2014: A dose of ACAM2000 (lot number was not reported, manufacturer: Sanofi Pasteur Biologics Co.), route was reported as "intradermal" in the left arm. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history and current illnesses were reported as none. The prior vaccination details and other medications were not reported. On 13-Nov-2014, 4 days post-vaccination, the patient developed malaise, headache and spinal pain resulting in hospitalization on an unspecified date. Laboratory investigation included a spinal tap that showed an elevated white count consistent with meningitis. Corrective treatment was not reported. At the time of this report, the patient's outcome was recovered. List of Documents held by sender: none.
Age: 43.0
Sex: M
Vaccine: ANTH, FLUX, HEP, SMALL
Symptoms: Adverse event, Laboratory test normal
Clinical narrative: This unsolicited case was received on 22-May-2015 via a third party query tool search on the VAERS database, under reference number 560033. A 43-year-old male patient received the following vaccinations on 11-Jul-2012: A dose of ACAM2000 (lot number was not reported, manufacturer: Sanofi Pasteur Biologics Co.), route was not reported and site was reported as unknown, a dose of Anthrax vaccine (lot number was not reported), manufacturer: other, route and site were unknown, a dose of Hep B vaccine (lot number was not reported), manufacturer, route and site of vaccination were unknown and a dose of Influenza vaccine (lot number was not reported) manufacturer, route and site of vaccination were unknown. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no medical history, other medications or current illnesses. The prior vaccination details were not reported. On 12-Jul-2012, 1 day post-vaccination, the patient experienced an unspecified event. Laboratory investigation was reported as normal. Corrective treatment was not provided. At the time of this report, the patient had recovered from the event.